Why HIV? HIVMA members Elizabeth Sherman, PharmD, and Julia Rosebush, DO, FAPP, FPIDS, share what led them to the field of HIV and what continues to drive their commitment today. Learn more about a career in HIV: https://www.hivma.org/

HIVMA Past Chair Judith Feinberg, MD, FACP, FIDSA, submitted testimony on behalf of the Ryan White Medical Providers Coalition, highlighting the urgency of increasing funding for the Ryan White Program in addition to HIV prevention and research. Read her testimony: https://bit.ly/4dWBg6E

As the HIV community marks 45 years since the CDC’s first HIV/AIDS report, the House has advanced a bill that would upend decades of hard-won progress in the fight against HIV. We call on Congress to reject these proposals and fund federal HIV programs: https://bit.ly/4e3ymxf

Advocates, health care providers, and allies gathered on the U.S. Capitol Grounds for yesterday's #CostOfSurvival Rally, calling on Congress to address rising health care costs, threats to HIV programs and Medicaid, and housing and food security.

This #PrideMonth, IDSA and HIVMA reaffirm our commitment to inclusion, diversity, access and equity. Advancing health equity means ensuring everyone has a fair and just opportunity to achieve optimal health. 🌈 Learn more: https://bit.ly/4o0ouZw

The president's FY 2027 budget proposal calls for the elimination of CDC’s HIV prevention program, Ryan White Program Part F, the HOPWA Program, as well as a 12% cut to NIH. Urge Congress to sustain and grow funding for federal HIV programs in FY 2027: bit.ly/4uc0tRM

Join advocates, health care providers, and allies at the #CostOfSurvival Rally this Wednesday, June 3 at 12pm ET on the U.S. Capitol Grounds to demand action to protect Medicaid, HIV funding, and the essential services people rely on to survive. Learn more and register: https://bit.ly/3PQyiJ8

ICYMI, HIVMA member Darrell McBride, DO, FIDSA, shares the realities of delivering HIV and infectious diseases care in rural communities in a new #LetsTalkID podcast. Available wherever you listen to podcasts. Search “Let’s Talk ID.” Transcript: bit.ly/4dR33Xi

Learn practical strategies to scale long-acting anti-retrovirals in diverse clinical settings during our webinar next Friday, June 5 at 1pm ET, featuring speakers Meredith Lora, MD, and Jonathan Colasanti, MD, of Emory University School of Medicine. Register: https://bit.ly/4u0HIzy

In a new submitted testimony, HIVMA Chair Anna K. Person, MD, FIDSA, urges the Senate Appropriations Subcommittee on LHHS to increase FY 2027 funding for HIV care, prevention and research programs, emphasizing that merely sustaining these programs is no longer adequate. Read: https://bit.ly/4u4ALxJ

On #IDPharmacistsDay, HIVMA celebrates pharmacists like Board member Sheila Montalvo, PharmD, whose expertise is vital in ensuring patients can access and maintain effective HIV treatment and prevention medications, including new long-acting options.

Missed last week's Advocacy Day? Join IDSA’s and HIVMA’s Member Advocacy Program (MAP)! Advocate with your colleagues on issues that impact the ID and HIV landscape and develop relationships with key stakeholders on the Hill. Learn more: https://bit.ly/3Z44hHR

Last month, Amesika Nyaku, MD, and Hanan Abdulahi, MPP, presented at the NMAC Biomedical HIV Prevention Summit, highlighting the importance of syndemic care education. Learn more about syndemic care resources: https://bit.ly/4v0YdwD

Today marks National Asian & Pacific Islander HIV/AIDS Awareness Day, a time to raise awareness of the impact of HIV, risk, and stigma surrounding HIV in the Asian Pacific Islander (API) community. Learn more this #NAPIHAAD: https://bit.ly/4dzJykO

New #LetsTalkID out now!🎙️ Host @matih-id.bsky.social is joined by Darrell McBride, DO, FIDSA, former program director & founder of the Geisinger Ryan White Program, to discuss the realities of delivering HIV & ID care in rural communities. Available on all podcast apps. Transcript: bit.ly/4dR33Xi

This HIV Vaccine Awareness Day, explore AVAC’s roadmap for advancing HIV vaccine research and development, highlighting critical gaps such as the need for a shared target product profile, stronger coordination, and sustained political support to accelerate progress. https://bit.ly/3RN9Usg

Thank you to the office of @warren.senate.gov for meeting with our members, Dr. Philip Bolduc, Dr.Andrea Ciaranello and HIV nurse Mary Piecewicz, about the importance of sustained federal funding for HIV programs.

A beautiful day for advocating for HIV funding!

Thank you @repgregstanton.bsky.social for your and your staff’s strong support of funding for federal HIV programs including the Ryan White Program and HIV prevention at the CDC. #SaveHIVFunding

HIMVA board members @acthornton.bsky.social, Nada Fadul, MD, FIDSA, and past chair Judith Feinberg, MD, FIDSA, are on Capitol Hill, advocating on the importance of HIV funding.

It’s Hill Day! Thank you @captmarkkelly.bsky.social for meeting with us and Dr. Sudha Nagalingam today to discuss how Ryan White Program cuts in Arizona are impacting people with HIV, the benefits of HIV research to new cancer treatments and more.

In preparation for tomorrow’s HIVMA Advocacy Day, join your colleagues and take action from home by contacting Congress to urge them to support funding for federal HIV programs: https://bit.ly/4uc0tRM

The April 2026 ADAP Watch highlights growing fiscal pressures on AIDS Drug Assistance Programs as rising drug and insurance costs put HIV care and treatment access at risk. Read more: https://bit.ly/4u0rgjB

#IDWeek2026 registration is NOW OPEN for all partner society members! Join us in person in Washington, DC, Oct. 21–24, or attend virtually from anywhere in the world. 🌍 Register today and save: www.idweek.org/registration

With more than 20 states implementing or considering cuts to their AlDS Drug Assistance Programs due to fiscal constraints, now is the time to connect with your state's ADAP staff. Learn five questions advocates should be asking about their ADAP's fiscal outlook: savehivfunding.org/5-questions-...

A new data brief found that 68% of respondents reported operational changes in HIV clinics from early Nov. to early Dec. 2025, with top impacts in gender-affirming care, case management/navigation, and housing-related supports. Read the brief: https://bit.ly/4tTU7WA

Thank you @degette.house.gov for speaking up at last week’s FY27 HHS budget hearing and highlighting the real-world consequences of HIV funding instability. Protecting access to HIV prevention and care saves lives, and setbacks put progress at risk.

Is your state considering restrictions on HIV drugs? HIVMA’s policy brief offers key recommendations for state policymakers to reform prior authorization requirements, improve access to HIV medications and reduce health care costs. Read the brief: https://bit.ly/4k3uO0n

A fair price for Biktarvy is vital to ensure Medicare beneficiaries can access effective HIV treatment & help end the HIV epidemic, stressed HIVMA board member Joseph Cherabie, MD, MSc, at yesterday's CMS Medicare Drug Pricing Program townhall. Dr. Cherabie’s comments: www.hivma.org/globalassets...

A new survey from The Well Project found that 72% of women and nonbinary people living with HIV in the U.S. reported experiencing stigmatizing language in healthcare settings, many citing negative effects on mental health and well-being. Read the report: https://bit.ly/48joc9H

The president’s FY 2027 budget proposal calls for deep cuts to HIV prevention, care and research and includes a proposed elimination of HIV Prevention and Ryan White Program Part F, which would come at a high cost. Learn more: bit.ly/3OPPDRQ

Today marks National Transgender HIV Testing Day, a day to recognize the importance of routine HIV testing, status awareness, and continued focus on HIV prevention and treatment efforts among transgender and gender non-binary people. Learn more: https://bit.ly/4tIhcLM

jidjournal.bsky.social is seeking proposals for papers focused on the use of long-acting antiretroviral therapies that explore new and innovative approaches to HIV care. Learn more and submit your proposal by May 24: https://bit.ly/4ckQMZr

Biktarvy is 1 of 15 drugs that will be subject to Medicare price negotiations in 2028. To help inform the process, CMS is hosting a town hall next Wednesday, April 22 at 10:30am-12pm ET, ft. HIVMA Board member Joseph Cherabie, MD, MSc. Learn more: https://go.cms.gov/48MGHmU

DYK? Anyone having sex can get an STI. This STI Awareness Week, know your STI care options and Get Yourself Tested! https://bit.ly/4dTyyh7 #GYT #STIweek

The Panel on Treatment of HIV During Pregnancy & Prevention of Perinatal Transmission has updated the Recommendations for the Use of Antiretroviral Drugs During Pregnancy & Interventions to Reduce Perinatal HIV Transmission in the U.S. guidelines sections: https://bit.ly/4tM8f48

Today marks National Youth HIV & AIDS Awareness Day, a day to take action regarding the impact of HIV/AIDS on young people and to highlight the HIV prevention, treatment, and care campaigns of young people in the U.S. Learn more: https://bit.ly/4snaCsP

The #IDWeek2025 Edward H. Kass Lecture is now available to the public! Watch HIVMA Past Chair Judith Feinberg, MD, FIDSA, reflect on early AIDS treatments and review key treatments and effective prophylaxis interventions from early research in HIV: https://bit.ly/41t23lo

Why HIV? HIVMA members share what inspired them to enter the field and what continues to motivate their work today. Learn more about a career in HIV: https://www.hivma.org/

The President’s proposal to slash HIV public health programs is a dangerous one at a time when states are already making unprecedented cuts to HIV services due to rising costs. Our statement: www.hivma.org/news/news_an...

A record 130 congressional members signed a letter to the House Labor-HHS Appropriations Subcommittee requesting increased funding for domestic HIV prevention, treatment and research. Read the letter: https://bit.ly/3PLHLRv

Florida update: Gov. DeSantis signed HB 697 providing $30 million for FL ADAP through June, helping 11,000+ people with HIV regain access to treatment. But it’s only temporary. Key meds and premium help are still missing. 📢 Urge lawmakers to fully restore FL ADAP. Learn more: https://bit.ly/3NZJthF

Today marks Transgender Day of Visibility, a time to celebrate resilience, honor transgender and gender-expansive people, and advocate for justice. 🏳️‍⚧️ Today, and every day, we stand in solidarity with our transgender colleagues, patients, and community members. Graphic via pflag.org

In a new cidjournal.bsky.social article, authors found that nearly one third of people who are virally suppressed are AIDS Drug Assistance Program (ADAP) clients despite ADAPs serving less than 25% of people with HIV in the U.S. Read more: https://bit.ly/4bJmVL7

On-demand sessions/symposia from #IDWeek2025 are available, but not for long! ⏰ All 2025 registrants have access to on-demand content through TOMORROW, March 31: https://idweek2025.eventscribe.net/

HIVMA’s policy brief highlights recommendations for state policymakers to reform prior authorization requirements, improve access to HIV medications and reduce health care costs. Read the brief: https://bit.ly/4tiGmAt

Global #HIV research funded by the U.S. has driven major breakthroughs like PrEP and treatment as prevention, delivering direct benefits to Americans. A recent Health Affairs article details how funding cuts now threaten future progress: https://bit.ly/4dMueD7

This Women's History Month, we’re celebrating women whose work is shaping the future of HIV medicine. In 2025, HIVMA was pleased to honor Rena Patel, MD, MPH, MPhil, of the University of Alabama at Birmingham with the HIVMA Innovator Award for her research that has directly impacted public health.

Stigma about tuberculosis prevents people from accessing the quality care they deserve and need. Help bring awareness and combat stigma this #WorldTBDay: https://bit.ly/4sY7rZi

Pre-Exposure Prophylaxis (PrEP) is one of the greatest inventions in medical history, says HIVMA Chair Anna K. Person, MD, FIDSA, in recent JAMA article. However, even as new options like lenacapavir expand prevention tools, barriers to access remain. Read more: bit.ly/3NGEhPo